BellRing Brands Earnings Call Transcripts
Fiscal Year 2026
-
Q2 net sales grew 2% year-over-year, but profitability was pressured by higher costs, unfavorable sales mix, and an $11M inventory charge. Full-year guidance was lowered, with flat to 2% net sales growth and 14% adjusted EBITDA margin expected as competitive and inflationary headwinds persist.
-
Q1 results exceeded expectations with 1% net sales growth and strong Dymatize international performance. FY2026 guidance narrowed to 4%-6% sales growth and $425-$440M Adjusted EBITDA, factoring in higher input costs and increased promotions. CEO transition announced.
-
The meeting covered director elections, auditor ratification, and executive compensation, with all proposals passing by strong majorities. No shareholder questions were raised during the session.
Fiscal Year 2025
-
Convenient nutrition leader expects continued growth as category penetration rises, supported by strong brand equity, innovation, and expanded retail partnerships. Margin pressures from inflation and tariffs are being addressed through cost savings and pricing, with long-term targets intact.
-
Fiscal 2025 saw 16% net sales growth and strong profitability, with Premier Protein leading category gains. 2026 guidance anticipates a softer Q1 but expects acceleration in later quarters, despite input cost inflation, tariffs, and increased competition.
-
Net sales rose 6% to $548 million, with adjusted EBITDA at $120 million and strong category leadership. Guidance for fiscal 2025 was tightened, with continued margin pressure from input costs and tariffs expected in 2026. Premier Protein and innovation remain key growth drivers.
-
Q2 net sales rose 19% year-over-year, with Premier Protein driving strong growth and record market share. Fiscal 2025 guidance was affirmed, though Q3 faces headwinds from retailer inventory reductions and input-cost inflation. Robust innovation and expanded promotions support long-term growth.
-
Q1 net sales and adjusted EBITDA grew over 24% year-over-year, driven by Premier Protein's strong performance and expanded marketing. Full-year guidance was raised, with robust category growth and innovation fueling confidence despite input cost pressures.
Fiscal Year 2024
-
Net sales and adjusted EBITDA grew 20% and 30% year-over-year, respectively, with Premier Protein and Dymatize driving record market share and household penetration. Fiscal 2025 guidance calls for 12%-16% sales growth and increased marketing spend, with margins pressured by input cost inflation.
-
Net sales rose 16% and adjusted EBITDA 38% year-over-year, led by Premier Protein's strong growth and improved margins. Full-year guidance was raised, with incremental production capacity secured and robust cash flow supporting share repurchases.